Firm News

The Latest News from Lucosky Brookman

Lucosky Brookman is a leader in the representation of small and micro-cap companies. The Firm has led it clients through numerous capital raise transaction and over a dozen uplisting and initial public offering transactions.  Access the latest news about Lucosky Brookman, our clients’ business transactions and industry updates here. 

Lucosky Brookman LLP Serves as Special NASDAQ Counsel to Mangoceuticals, Inc. in Connection with Successful IPO

Lucosky Brookman LLP is proud to announce its role as Special NASDAQ Counsel to Mangoceuticals, Inc. ("MangoRx" or the "Company"), a company focused on developing, marketing and selling a variety of men's health and wellness products via a secure telemedicine platform, in pricing of its initial public offering of 1,250,000 shares of its common stock at a public offering price of $4.00 per share for a total of $5,000,000 of gross proceeds to the Company. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 187,500 shares of its common stock at the public offering price of $4.00 per share, less the underwriting discounts and commissions, to cover over-allotments, if any.

Lucosky Brookman LLP provided strategic and legal guidance to Mangoceuticals, enabling the company to achieve success in the IPO. The firm's seasoned securities lawyers have in-depth knowledge and experience in dealing with the legal and regulatory requirements associated with going public. They worked closely with Mangoceuticals throughout the IPO process to help the company meet NASDAQ's stringent listing standards and compliance requirements, which were vital to the success of the offering.

Lucosky Brookman LLP played a pivotal role in advising the company on the nuances of NASDAQ's rules and regulations, the preparation of the prospectus, and the filing of the registration statement. They were also instrumental in providing guidance to the company on the preparation of its governance and compliance policies, which are essential to maintaining the company's status as a publicly traded entity.

Lucosky Brookman LLP congratulates Mangoceuticals on its successful IPO and looks forward to continuing its work with the company in achieving its strategic goals. The firm's seasoned securities lawyers are committed to providing clients with strategic and legal guidance to navigate the complexities of the capital markets. They have the experience and knowledge necessary to provide clients with tailored solutions that meet their unique business objectives.